• On July 7, 2026, activist investor Reference Equity released a letter and presentation to CBIZ’s Board, urging the company to halt share repurchases, resume its acquisition program, and raise equity capital to reposition the business for future growth.
• This intervention puts CBIZ’s capital allocation under the spotlight, questioning whether buybacks or renewed deal-making are better aligned with its growth ambitions.
• We’ll now examine how Reference Equity’s push to suspend buybacks and restart acquisitions may reshape CBIZ’s existing investment narrative.

Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

CBIZ Investment Narrative Recap

To own CBIZ, you need to believe its enlarged platform can turn scale, recurring compliance work, and technology investments into steadier earnings, despite pricing pressure and nonrecurring advisory exposure. Reference Equity’s call to halt buybacks and restart acquisitions directly touches the key near term catalyst of improved capital allocation, while also sharpening attention on the biggest current risk around elevated leverage and integration-related execution.

The most relevant recent update is CBIZ’s ongoing buyback activity, with 2,552,000 shares repurchased for US$168.83 million under the February 2024 program and a new authorization of up to 5,000,000 shares through March 2027. Reference Equity’s proposal effectively challenges whether this repurchase focus remains the best use of cash given modest 2026 revenue guidance of US$2.8 billion to US$2.9 billion and continued integration and debt obligations that still weigh on financial flexibility.

Yet beneath the headline debate on buybacks, investors should be aware that integration costs and leverage tied to Marcum could still...

CBIZ’s narrative projects $3.0 billion revenue and $216.3 million earnings by 2029. This requires 3.3% yearly revenue growth and about a $62 million earnings increase from $154.3 million today.

Uncover how CBIZ's forecasts yield a $41.00 fair value, in line with its current price.

Exploring Other Perspectives

Compared with consensus, the lowest analysts were already more cautious, assuming only about US$3.1 billion of revenue and US$223.1 million of earnings by 2029, so Reference Equity’s push to shift cash from buybacks to acquisitions might either ease their integration concerns or deepen worries about execution and debt, depending on how you view the extra risk.

Explore 2 other fair value estimates on CBIZ - why the stock might be worth over 2x more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your CBIZ research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
• Our free CBIZ research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CBIZ's overall financial health at a glance.

Contemplating Other Strategies?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• The future of work is here. Discover the 32 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find 47 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.